Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank56
3Y CAGR-37.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-37.9%/yr
Annual compound
Percentile
P56
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.49 | -48.1% |
| 2024 | 4.79 | -92.6% |
| 2023 | 64.77 | +522.7% |
| 2022 | 10.40 | -49.6% |
| 2021 | 20.64 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |